Defence minister Rajnath Singh released the first first batch of the 2-deoxy-D-glucose (2-DG) drug developed by the Defence Research and Development Organisation (DRDO) for treatment of Covid-19 on Monday.The anti-COVID therapeutic application of the drug has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a leading laboratory of the DRDO, in collaboration with Dr Reddy's Laboratories (DRL) in Hyderabad. The drug comes in a powder form in a sachet and is taken orally by dissolving it in water, the ministry said.In efficacy trends, it said, patients treated with 2-DG showed a faster symptomatic cure than the standard of care (SoC) on various endpoints.

Defence minister Rajnath Singh released the first first batch of the 2-deoxy-D-glucose (2-DG) drug developed by the Defence Research and Development Organisation (DRDO) for treatment of Covid-19 on Monday.The anti-COVID therapeutic application of the drug has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a leading laboratory of the DRDO, in collaboration with Dr Reddy's Laboratories (DRL) in Hyderabad. The drug comes in a powder form in a sachet and is taken orally by dissolving it in water, the ministry said.In efficacy trends, it said, patients treated with 2-DG showed a faster symptomatic cure than the standard of care (SoC) on various endpoints.